MAPT and HIV-associated neurocognitive disorder: Kang et al. (2010) also demonstrated neuroprotection with a murine model of human immunodeficiency virus-associated neurocognitive disorders (HAND), finding that intranasal EPO + IGF-I act synergistically to activate signaling pathways which decrease the hyperphosphorylation of tau protein [19].